JP2010501596A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010501596A5 JP2010501596A5 JP2009525863A JP2009525863A JP2010501596A5 JP 2010501596 A5 JP2010501596 A5 JP 2010501596A5 JP 2009525863 A JP2009525863 A JP 2009525863A JP 2009525863 A JP2009525863 A JP 2009525863A JP 2010501596 A5 JP2010501596 A5 JP 2010501596A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- pharmaceutical composition
- group
- condition
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 13
- 206010028980 Neoplasm Diseases 0.000 claims 7
- 201000011510 cancer Diseases 0.000 claims 7
- 239000008267 milk Substances 0.000 claims 7
- 210000004080 milk Anatomy 0.000 claims 7
- 235000013336 milk Nutrition 0.000 claims 7
- 241000124008 Mammalia Species 0.000 claims 6
- 230000003463 hyperproliferative effect Effects 0.000 claims 6
- 208000023514 Barrett esophagus Diseases 0.000 claims 4
- 208000023665 Barrett oesophagus Diseases 0.000 claims 4
- 102100031983 Ephrin type-B receptor 4 Human genes 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 210000004962 mammalian cell Anatomy 0.000 claims 4
- 230000002265 prevention Effects 0.000 claims 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims 4
- 206010005003 Bladder cancer Diseases 0.000 claims 2
- 206010008342 Cervix carcinoma Diseases 0.000 claims 2
- 108010055334 EphB2 Receptor Proteins 0.000 claims 2
- 102100030779 Ephrin type-B receptor 1 Human genes 0.000 claims 2
- 102100031968 Ephrin type-B receptor 2 Human genes 0.000 claims 2
- 208000000461 Esophageal Neoplasms Diseases 0.000 claims 2
- 206010017993 Gastrointestinal neoplasms Diseases 0.000 claims 2
- 101001064150 Homo sapiens Ephrin type-B receptor 1 Proteins 0.000 claims 2
- 208000001894 Nasopharyngeal Neoplasms Diseases 0.000 claims 2
- 206010061306 Nasopharyngeal cancer Diseases 0.000 claims 2
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims 2
- 206010031096 Oropharyngeal cancer Diseases 0.000 claims 2
- 206010057444 Oropharyngeal neoplasm Diseases 0.000 claims 2
- 201000004681 Psoriasis Diseases 0.000 claims 2
- 208000000453 Skin Neoplasms Diseases 0.000 claims 2
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 2
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims 2
- 201000010881 cervical cancer Diseases 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 201000004101 esophageal cancer Diseases 0.000 claims 2
- 208000024519 eye neoplasm Diseases 0.000 claims 2
- 230000002163 immunogen Effects 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 230000002458 infectious effect Effects 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 201000008106 ocular cancer Diseases 0.000 claims 2
- 201000006958 oropharynx cancer Diseases 0.000 claims 2
- 208000022131 polyp of large intestine Diseases 0.000 claims 2
- 201000000849 skin cancer Diseases 0.000 claims 2
- 201000005112 urinary bladder cancer Diseases 0.000 claims 2
- 206010046885 vaginal cancer Diseases 0.000 claims 2
- 208000013139 vaginal neoplasm Diseases 0.000 claims 2
- 210000003238 esophagus Anatomy 0.000 claims 1
- 210000001035 gastrointestinal tract Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000009885 systemic effect Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2006904752A AU2006904752A0 (en) | 2006-08-31 | Uses for Antibodies | |
| PCT/AU2007/001282 WO2008025099A1 (en) | 2006-08-31 | 2007-08-31 | Treatment and/or prevention of non-infectious medical conditions using antibody-containing compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010501596A JP2010501596A (ja) | 2010-01-21 |
| JP2010501596A5 true JP2010501596A5 (cg-RX-API-DMAC7.html) | 2010-09-16 |
Family
ID=39135433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009525863A Pending JP2010501596A (ja) | 2006-08-31 | 2007-08-31 | 抗体含有組成物を用いた非感染性の病状の処置および／または予防 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20100297140A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2061510B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2010501596A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101626784B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2007291891B2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK2061510T3 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ575918A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2008025099A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009046168A1 (en) | 2007-10-02 | 2009-04-09 | Avaxia Biologics, Inc. | Antibody therapy for use in the digestive tract |
| EP3461840A1 (en) * | 2009-04-27 | 2019-04-03 | Immuron Limited | Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of non alcoholic steatohepatitis |
| JP2011026252A (ja) * | 2009-07-27 | 2011-02-10 | Kitasato Institute | 上皮成長因子受容体に対する卵黄抗体およびその用途 |
| CA2808361A1 (en) | 2010-08-17 | 2012-02-23 | Immuron Ltd. | Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of inflammatory bowel disease |
| KR102037885B1 (ko) | 2010-11-23 | 2019-10-30 | 팬더릭스 인코포레이티드 | 광범위한, 미확인 또는 혼합된 임상적 적용에서 치료용 조성물들 및 방법들 |
| KR20140031175A (ko) * | 2010-12-08 | 2014-03-12 | 스템 센트알엑스 인코포레이티드 | 신규 조절제 및 용법 |
| WO2012098256A1 (en) * | 2011-01-21 | 2012-07-26 | Université De La Méditerranée Aix - Marseille Ii | Anti-cd146 auto-antibodies and uses thereof |
| DE102011006809A1 (de) | 2011-04-05 | 2012-10-11 | Freistaat Bayern vertreten durch die Julius-Maximilians-Universität Würzburg | Verwendung eines Mittels aus Antikörpern und/oder Insulin-like growth factor-Antagonisten |
| CA2857597A1 (en) * | 2011-11-30 | 2013-06-06 | AbbVie Deutschland GmbH & Co. KG | Methods and compositions for determining responsiveness to treatment with a tnf-alpha inhibitor |
| BR112016010051A2 (pt) | 2013-11-04 | 2017-12-05 | Pfizer | ?conjugados de anticorpo-fármaco anti-efna4? |
| RO130965A8 (ro) * | 2015-10-16 | 2017-06-30 | Romvac Company S.A. | Producerea şi utilizarea oului hiperimun personalizat () în tratamentul psoriazisului |
| US10792320B2 (en) * | 2018-03-28 | 2020-10-06 | Michael Alan Beller | Methods for treatment of bladder dysfunction |
| WO2020176637A1 (en) | 2019-02-26 | 2020-09-03 | Pantheryx, Inc. | Compositions for management of disorders of the gastrointestinal tract |
| US11319382B1 (en) | 2021-06-28 | 2022-05-03 | King Abdulaziz University | Methods for producing and using IgY antibodies targeting the middle east respiratory syndrome coronavirus spike protein to treat or prevent MERS-CoV infection |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3911108A (en) * | 1973-02-14 | 1975-10-07 | Diamond Shamrock Corp | Process of producing bovine milk products containing specific antibodies |
| AUPN642795A0 (en) * | 1995-11-08 | 1995-11-30 | Northfield Laboratories Pty Ltd | Dairy compositions and methods of preparing same |
| WO1998014209A1 (en) * | 1996-10-02 | 1998-04-09 | Ovimmune, Inc. | Oral administration of chicken yolk antibodies to treat disease |
| WO1999036077A1 (en) * | 1998-01-19 | 1999-07-22 | Dcv, Inc. | Composition and method for treatment and prevention of arthritis and/or autoimmune diseases |
| EP1085906B1 (en) * | 1998-06-10 | 2008-08-13 | Ophidian Pharmaceuticals, Inc. | Anti il6 antibodies in the prevention and treatment of inflammatory bowel disease |
| CN1163511C (zh) * | 1999-10-22 | 2004-08-25 | 徐永华 | 鸡卵黄抗白细胞介素-8抗体、制备方法及其应用 |
| CN1303889A (zh) | 1999-12-20 | 2001-07-18 | 陶氏康宁东丽硅氧烷株式会社 | 用于嵌件模塑或双模腔模塑的硅橡胶组合物 |
| JP2005298332A (ja) * | 2000-09-28 | 2005-10-27 | Shibayagi:Kk | 過剰自己抗体産生抑制物質、その製造法およびその使用方法 |
| CN100571715C (zh) * | 2002-03-21 | 2009-12-23 | 阿纳迪斯有限公司 | 含有生物活性物质的组合物及其制备和处理方法 |
| CN1199672C (zh) | 2002-04-17 | 2005-05-04 | 李永忠 | 一套预防与治疗癌症中成药 |
| CN1377894A (zh) * | 2002-04-23 | 2002-11-06 | 郭占军 | 蛋黄抗癌抗体制备方法及其应用 |
| AU2002951409A0 (en) * | 2002-09-16 | 2002-09-26 | North Western Adelaide Health Services | Methods for regulating cancer |
| JP4264894B2 (ja) * | 2004-03-01 | 2009-05-20 | 三菱自動車工業株式会社 | エアボックス付きグローブボックス |
| NZ549787A (en) * | 2004-03-12 | 2010-05-28 | Vasgene Therapeutics Inc | Antibodies binding to EphB4 for inhibiting angiogenesis and tumor growth |
| WO2006047298A2 (en) * | 2004-10-21 | 2006-05-04 | The Penn State Research Foundation | Eph receptor tumor biomarkers |
| WO2006083936A2 (en) * | 2005-01-31 | 2006-08-10 | Genentech, Inc. | Anti-ephb2 antibodies and methods using same |
| WO2007026689A1 (ja) * | 2005-08-29 | 2007-03-08 | Japan Science And Technology Agency | ダチョウを用いた抗体、及びその作製方法 |
-
2007
- 2007-08-31 EP EP07800240.9A patent/EP2061510B1/en not_active Not-in-force
- 2007-08-31 DK DK07800240.9T patent/DK2061510T3/en active
- 2007-08-31 CN CN200780039676XA patent/CN101626784B/zh not_active Expired - Fee Related
- 2007-08-31 AU AU2007291891A patent/AU2007291891B2/en not_active Ceased
- 2007-08-31 US US12/310,643 patent/US20100297140A1/en not_active Abandoned
- 2007-08-31 NZ NZ575918A patent/NZ575918A/en unknown
- 2007-08-31 JP JP2009525863A patent/JP2010501596A/ja active Pending
- 2007-08-31 WO PCT/AU2007/001282 patent/WO2008025099A1/en not_active Ceased
-
2013
- 2013-06-26 US US13/927,491 patent/US8834872B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010501596A5 (cg-RX-API-DMAC7.html) | ||
| Abourehab et al. | Alginate as a promising biopolymer in drug delivery and wound healing: A review of the state-of-the-art | |
| Sachdeva et al. | Chitosan nanoparticles-based cancer drug delivery: application and challenges | |
| Vashist et al. | Recent advances in hydrogel based drug delivery systems for the human body | |
| US10441760B2 (en) | Self-actuating chemomechanical devices for delivery and extended release of therapeutic agents in the gastrointestinal tract | |
| Jawadi et al. | Bio-inspired muco-adhesive polymers for drug delivery applications | |
| WO2017028777A1 (zh) | 贻贝粘蛋白产品及其抑制粘膜炎症的应用 | |
| EA032034B1 (ru) | Наночастицы двукратно дериватизованного хитозана и способы их получения и применения для переноса генов in vivo | |
| JP2016515113A5 (cg-RX-API-DMAC7.html) | ||
| JP2019031521A5 (cg-RX-API-DMAC7.html) | ||
| CA3160114A1 (en) | New multi-functional oligopeptides | |
| JP2010500284A5 (cg-RX-API-DMAC7.html) | ||
| Lu et al. | Supramolecular self-assembled hydrogel for antiviral therapy through glycyrrhizic acid-enhanced zinc absorption and intracellular accumulation | |
| WO2013177927A1 (zh) | 注射用埃索美拉唑钠冻干粉组合物及其制备方法 | |
| US20180179543A1 (en) | Device and method to treat esophageal disorders | |
| CN102964335B (zh) | 一种埃索美拉唑钠化合物及其制备方法和用途 | |
| CN106474472A (zh) | 肿瘤曲妥珠单抗靶向anti‑miR‑21纳米粒子及其制备方法 | |
| WO2013177963A1 (zh) | 注射用泮托拉唑钠冻干粉组合物及其制备方法 | |
| TW201446267A (zh) | 醫藥用載體及使用該載體的藥物結構 | |
| GR20180100090A (el) | Φαρμακευτικο σκευασμα σε μορφη γελης για ασθενεις με ηωσινοφιλικη οισοφαγιτιδα | |
| Xu | BIDIRECTIONAL THERMORESPONSIVE GRIPPERS FOR MACROMOLECULAR DRUG DELIVERY | |
| Xiao et al. | Emerging novel hydrogels application in oral and gastrointestinal diseases: design wet adhesive strategy towards possible mechanisms | |
| AU2021349286B2 (en) | Vaccine compositions for mucosal immune response | |
| CN110917478B (zh) | 一种宫颈hpv感染用药物缓释器 | |
| RU2463055C2 (ru) | Способ лечения воспалительных заболеваний кишечника |